The US Food and Drug
Administration (FDA) has revised
the label of the antibacterial drug
Doribax (doripenem) to include
a warning about using it to treat
pneumonia.
The FDA said it had been used
to treat patients who develop
pneumonia while on ventilators
and it had found an increased
risk of death and lower cure rates
compared with other drugs.
The FDA said Doribax was still
safe and effective for its approved
indications including treatment of
adults with complicated intraabdominal
infections.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Mar 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.